Kaleb Yohay

Also affiliated with New York University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation”.

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

Genetics in Medicine(2022)10.1016/j.gim.2022.05.007

N/A

0.846DataRank · unranked

281 citations

Ludwine Messiaen, Eric Legius, Patrice Pancza, Robert A. Avery, Jaishri O. Blakeley +79 more

Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2

Science Translational Medicine(2020)10.1126/scitranslmed.abb5413

N/A

0DataRank · unranked

74 citations

Stephen M. Kaminsky, Neil R. Hackett, Odelya E. Pagovich, Jonathan B. Rosenberg, Bishnu P. De +19 more

The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa095

N/A

0DataRank · unranked

38 citations

Eva H. Baker, Andrea M. Gross, Patricia Whitcomb, Andrea Baldwin, Joanne Derdak +9 more

Awareness and Agreement with Neurofibromatosis Care Guidelines among Neurofibromatosis Specialists

medRxiv(2021)10.1101/2021.06.16.21259047

N/A

0DataRank · unranked

0 citations

Pamela Knight, Heather B. Radtke, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin +2 more

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

medRxiv(2022)10.1101/2022.03.31.22273208

N/A

0DataRank · unranked

0 citations

Jan M. Friedman, Laura J. Klesse, Kaleb Yohay, Justin T. Jordan, Scott R. Plotkin +3 more

Phase II study of axitinib in patients with NF2-related schwannomatosis and progressive vestibular schwannomas

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf083

N/A

0DataRank · unranked

1 citations

Mari Hagiwara, Anna Yaffe, Carole Mitchell, Srivandana Akshintala, Theodore Nicolaides +7 more